Site Search
410 result(s) found for “ adaptive therapy”
-
21MA026N Method: Combination Therapy of Polio Virus Receptor Inhibitors and Fucose
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICEThe Innovation Dedicated to supporting patients every step of the way, with...
-
Adding Inhibitor to Hormonal Therapy Reduces Risk of Breast Cancer Recurrence
Phase 3 trial results could be practice changing for both men and women
-
Aquablation Therapy Expands Treatment Options for Patients With Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH), also known as enlarged prostate, is one of the most common urologic conditions affecting aging men, affecting...
-
Could Adding a Targeted Therapy Before Surgery Change Prostate Cancer Care?
Phase 3 trial suggests apalutamide with hormone therapy and surgery extends time before high risk prostate cancer returns or spreads
-
Global Clinical Trial Explores New Combination Therapy for Metastatic Breast Cancer
The ongoing VIKTORIA-1 Phase 3 trial targets patients with hormone receptor positive, HER2 negative breast cancer
-
Grand Opening of New Moffitt Clinic Dedicated to Immune Cell Therapy
The new clinic will focus on cellular immunotherapies such as chimeric antigen receptor T-cell therapy (CAR T), which reengineers a patient’s own...
-
Moffitt Bringing Proton Therapy to Tampa Bay for Cervical Cancer Patients
Moffitt will offer proton therapy in Tampa Bay beginning in 2026, providing advanced radiation treatment for cervical cancer with fewer side effects....
-
Moffitt Investigates First-of-Its-Kind Cellular Therapy in MDS Patients
Novel approach uses mismatched donor lymphocytes to activate patient’s immune system
-
New Oral Targeted Therapy Shows Benefit in Hard to Treat Cancers
Early phase trial results show signs of tumor response and disease control in patients with advanced melanoma, colon, ovarian, cervical and thymic...
-
Promises of Cell Therapy Bring Opportunities for Collaboration and Clinical Excellence
Finding ways to act on discrete targets on or within cancerous cells without affecting healthy cells is a key focus of several Moffitt research...